FDA NDC Directory · JSON-LD · Markdown

OXCARBAZEPINE

NDC 31722-687 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA216749
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOXCARBAZEPINE (60 mg/mL)
Marketing started20231020
Package count1

External sources

Source: openFDA. Public-domain (CC0).